Publications
-
Minuesa G, Huber-Ruano I, Pastor-Anglada M, Koepsell H, Clotet B and Martinez-Picado J.
Drug uptake transporters in antiretroviral therapy.
PHARMACOL THERAPEUT . 132(3): 268-279. Number of citations: 61
-
Fernández-Calotti PX, Colomer D and Pastor-Anglada M.
Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 30(12): 1324-1340. Number of citations: 14
-
Errasti-Murugarren E, ESTHER PATRICIA DIAZ GONZALEZ, Godoy V, Riquelme G and Pastor-Anglada M.
Expression and distribution of nucleoside transporter proteins in the human syncytiotrophoblast.
MOLECULAR PHARMACOLOGY . 80(5): 809-817. Number of citations: 23
-
Domingo P, Torres-Torronteras J, Pomar V, Giralt M, Domingo JC, Gutierrez Mdel M, Gallego-Escuredo JM, Mateo MG, Cano-Soldado P, Fernandez I, Pastor-Anglada M, Vidal F, Villarroya-Gombau F, Andreu A and Marti R.
Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
PLoS One . 5(11): . Number of citations: 10
-
Errasti-Murugarren E, Casado FJ and Pastor-Anglada M.
Different N-terminal motifs determine plasma membrane targeting of the human concentrative nucleoside transporter 3 in polarized and nonpolarized cells.
MOLECULAR PHARMACOLOGY . 78(5): 795-803. Number of citations: 14
-
Huber-Ruano I, Pinilla-Macua I, Torres G, Casado FJ and Pastor-Anglada M.
Link between high-affinity adenosine concentrative nucleoside transporter-2 (CNT2) and energy metabolism in intestinal and liver parenchymal cells.
J CELL PHYSIOL . 225(2): 620-630. Number of citations: 16
-
Gorraitz E, Pastor-Anglada M and Lostao MP.
Effects of Na+ and H+ on steady-state and presteady-state currents of the human concentrative nucleoside transporter 3 (hCNT3).
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY . 460(3): 617-632. Number of citations: 7
-
Errasti-Murugarren E, Molina-Arcas M, Casado FJ and Pastor-Anglada M.
The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.
MOLECULAR PHARMACOLOGY . 78(2): 157-165. Number of citations: 17
-
Errasti-Murugarren E and Pastor-Anglada M.
Drug transporter pharmacogenetics in nucleoside-based therapies.
Pharmacogenomics . 11(6): 809-841. Number of citations: 44
-
Molina-Arcas M and Pastor-Anglada M.
Role of nucleoside transporters in nucleoside-derived drug sensitivity.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 29(4-6): 335-346. Number of citations: 10